CYP2E1 and CYP4A appear to play significant roles in the development of NAFLD/NASH by promoting the accumulation of lipid, inflammation, and fibrosis through the generation of ROS and NADPH-dependent microsomal lipid peroxidation (43). The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.